Survival in hereditary breast cancer associated with germline mutations of BRCA2

Journal of Clinical Oncology

Volumn 17, Issue 11, 1999, Pages 3396-3402

  Verhoog, L C ^a   Brekelmans, C T M ^a   Seynaeve, C ^a   Dahmen, G ^a   Van Geel, A N ^a   Bartels, C C M ^a   Tilanus Linthorst, M M A ^a   Wagner, A ^a   Devilee, P ^a   Halley, D J J ^a   Van Den Ouweland, A M W ^a   Meijers Heijboer, E J ^a   Klijn, J G M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER SURVIVAL; FEMALE; GENE DELETION; GENE INSERTION; GENETIC LINKAGE; HETEROZYGOTE DETECTION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR DENSITY; SURVIVAL TIME;

EID: 0032703874     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1999.17.11.3396     Document Type: Article

References (44)

1. King MC: Genetic analysis of cancer in families, Cancer Surv 9:417-435, 1990
2. Miki Y, Swensen J, Shattuck Eidens D, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71, 1994
3. Wooster R, Bignell G, Lancaster J, et al: Identification of the breast cancer susceptibility gene BRCA2. Nature 378:789-792, 1995
4. Struewing JP, Hartge P. Wacholder S, et al: Cancer risk with 185delAG and 5382insC mutations of BRCA1 and the 6174delT mutation of BRCA2 among Ashkenazi Jews. N Engl J Med 336:1401-1408, 1997
5. Ford D, Easton DF, Bishop DT, et al: Risks of cancer in BRCA1 mutation carriers. Lancet 343:692-695, 1994
6. Ford D, Easton DF, Stratton M, et al: Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am J Hum Genet 62:676-689, 1998
7. Blackwood MA, Weber BL: BRCA1 and BRCA2: From molecular genetics to clinical medicine. J Clin Oncol 16:1969-1977, 1998
8. Narod S, Ford D, Devilee P, et al: Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 57:957-958, 1995
9. Serova O, Montagna M, Torchard D, et al: A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet 58:42-51, 1996
10. Anderson DE: Some characteristics of familial breast cancer. Cancer 28:1500-1505, 1971
11. Hall JM, Lee MK, Morrow J, et al: Linkage analysis of early onset familial breast cancer to chromosome 17q21. Science 250:1684-1689, 1990
12. Ligtenberg MJL, Hogervorst FBL, Willems HW, et al: Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2. Br J Cancer 79:1475-1478, 1999
13. Agnarsson BA, Jonasson JG, Björnsdottir IB, et al: Inherited BRCA2 mutation associated with high grade breast cancer. Breast Cancer Res Treat 47:121-127, 1998
14. Breast Cancer Linkage Consortium: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505-1510, 1997
15. Lynch BJ, Holden JA, Buys SS, et al: Pathobiological characteristics of hereditary breast cancer. Hum Pathol 29:1140-1144, 1998
16. Lakhani SR, Jacquemier J, Sloane JP, et al: Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138-1145, 1998
17. Lynch HT, Albano WA, Recabaren JA, et al: Survival in hereditary breast and colon cancer. JAMA 246:1197, 1981 (letter)
18. Wobbes T, van de Wiel MP, van der Sluis RF, et al: The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Sur Oncol 13:119-121, 1987
19. Lees AW, Jenkins HJ, May CL, et al: Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13:143-151, 1989
20. Malone KE, Daling JR, Weiss NS, et al: Family history and survival of young women with invasive breast carcinoma. Cancer 78:1417-1425, 1996
21. Marcus JN, Watson P, Page DL, et al: Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709, 1996
22. Verhoog LC, Brekelmans CTM, Seynaeve C, et al: Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1. Lancet 351:316-321, 1998
23. Watson P, Marcus JN, Lynch HT: Prognosis of BRCA1 hereditary breast cancer. Lancet 351:304-305, 1998
24. Johannsson OT, Ranstam J, Borg A, et al: Survival of BRCA1 breast and ovarian cancer patients: A population based study from Southern Sweden. J Clin Oncol 16:397-404, 1998
25. Gaffney DK, Brohet RM, Lewis CM, et al: Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol 47:129-136, 1998
26. Wagner TM, Moslinger RA, Muhr D, et al: BRCA1-related breast cancer in Austrian breast and ovarian cancer families: Specific BRCA1 mutations and pathological characteristics. Int J Cancer 77:354-360, 1998
27. Lee JS, Wacholder S, Struewing JP, et al: Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 91:259-263, 1999
28. Foulkes WD, Wong N, Brunet J-S, et al: Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer. Clin Cancer Res 3:2465-2469, 1997
29. Ansquer Y, Gautier C, Fourquet A, et al: Survival in early-onset BRCA1 breast-cancer patients. Lancet 352:541, 1998 (letter)
30. Foekens JA, Portengen H, van Putten WL, et al: Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols. Cancer Res 49:5823-5828, 1989
31. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, John Wiley. 1980
32. Coebergh JWW, van der Heijden LH, Janssen-Heijen MLG (eds): Cancer Incidence and Survival in the Southeast of the Netherlands 1955-1994. Eindhoven, the Netherlands. Comprehensive Cancer Center South, 1995
33. Sigurdsson H, Agnarsson BA, Jonasson JG, et al: Worse survival among breast cancer patients in families carrying the BRCA2 susceptibility gene. Breast Cancer Res Treat 367:33, 1996 (abstr 1)
34. Porter DE, Cohen BB, Wallace MR, et al: Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21. Br J Surg 81:1512-1515, 1994
35. Robson M, Gilewski T, Haas B, et al: BRCA-associated breast cancer in young women. J Clin Oncol 16:1642-1649. 1998
36. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al: A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 13:117-119, 1996
37. Neuhausen SL, Godwin AK, Gershoni-Baruch R, et al: Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: Results of an international study. Am J Hum Genet 62:1381-1388, 1998
38. Osin P, Crook T, Powles T, et al: Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers. Lancet 351:1487, 1998 (letter)
39. Robson M, Rajan P, Rosen PP, et al: BRCA-associated breast cancer: Absence of a characteristic immunophenotype. Cancer Res 58:1839-1842, 1998
40. Narod SA, Risch H, Moslehi R, et al: Oral contraceptives and the risk of hereditary ovarian cancer. N Engl J Med 229:424-428, 1998
41. Loman N, Johannsson O, Bendahl P-O, et al: Steroid receptors in hereditary breast carcinomas associated with BRCA1 and BRCA2 mutations or unknown susceptibility genes. Cancer 83:310-319, 1998
42. Osin P, Gusterson BA, Philp E, et al: Predicted anti-oestrogen resistance in BRCA-associated familial breast cancers. Eur J Cancer 34:1683-1686, 1998
43. Fisher B, Constantino JP, Wickerham DL, et al: Tamoxifen for prevention of breast cancer: Report of the national surgical adjuvant breast and bowel project P-1 study. J Natl Cancer Inst 90:1371-1388, 1998
44. Cady B: Familial bilateral cancer of the breast. Ann Surg 172:264-272, 1970